Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0A8OX
|
||||
Former ID |
DNC013580
|
||||
Drug Name |
N,N'-(1',5'-pentylene)-bis-(-)-nor-MEP
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529368] | ||
Structure |
Download2D MOL |
||||
Formula |
C33H50N2O2
|
||||
Canonical SMILES |
CCC1(CCCCN(C1)CCCCCN2CCCCC(C2)(CC)C3=CC(=CC=C3)O)C4=CC(<br />=CC=C4)O
|
||||
InChI |
1S/C33H50N2O2/c1-3-32(28-14-12-16-30(36)24-28)18-6-10-22-34(26-32)20-8-5-9-21-35-23-11-7-19-33(4-2,27-35)29-15-13-17-31(37)25-29/h12-17,24-25,36-37H,3-11,18-23,26-27H2,1-2H3/t32-,33?/m1/s1
|
||||
InChIKey |
XNVOHDDYQCZZQX-KWRHIPAJSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Acetylcholinesterase | Target Info | Inhibitor | [529368] | |
Cholinesterase | Target Info | Inhibitor | [529368] | ||
KEGG Pathway | Glycerophospholipid metabolism | ||||
Cholinergic synapse | |||||
PANTHER Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | ||||
Muscarinic acetylcholine receptor 2 and 4 signaling pathway | |||||
Nicotinic acetylcholine receptor signaling pathwayP00042:Muscarinic acetylcholine receptor 1 and 3 signaling pathway | |||||
Nicotinic acetylcholine receptor signaling pathway | |||||
Pathway Interaction Database | ATF-2 transcription factor network | ||||
PathWhiz Pathway | Phospholipid Biosynthesis | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.